Cell therapy for ischemic heart disease

Panminerva Medica

Volumn 46, Issue 1, 2004, Pages 13-23

  Bonaros, N ^a   Yang, S ^b   Ott, H ^b   Kocher, A ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Myocardial infarction; Regeneration; Stem cells

Indexed keywords

ADULTHOOD; ANGIOGENESIS; AUTOTRANSPLANTATION; CELL FUSION; CELL LINE; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPLANTATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CYTOKINESIS; DEFIBRILLATOR; EMBRYO CELL; FEASIBILITY STUDY; FETUS CELL; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INJECTION; ISCHEMIC HEART DISEASE; MESENCHYME CELL; MYOBLAST; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; REVIEW; SAFETY; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION; SUBSTITUTION THERAPY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLASTS, SKELETAL; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; VENTRICULAR REMODELING;

EID: 4143052523     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 2001.
2. Hognes JR. The artificial heart: prototypes, policies and patients. Washington: National Academy; 1991.
3. United States Department of Health and Human Services. Annual report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network. Washington: US Department of Health and Human Services; 1990.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-43.
5. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.
6. Agocha A, Lee HW, Eghali-Webb M. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of TGF-β1, thyroid hormone, angiotensin ligand basic fibroblast growth factor. J Mol Cell Cardiol 1997;29:2233H-44H.
7. Kalkman EA, Bilgin YM, van Haren P, van Suylen RJ, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996;32:1088-95.
8. Nelissen-Vrancken H, Debets J, Snoeckx L, Daemen M, Smiths J. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 1996;93:349-55.
9. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L et al. Inhibition of plasminogen activator or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-42.
10. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987;75:299-306.
11. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1992;20:307-13.
12. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
13. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-6.
14. Mc Lellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Ann Rev Physiol 2000;62:289-320.
15. Kellerman S, Moore JA, Zierhut, W, Zimmer HG, Campbell J, Gerdes AM et al. Nuclear DNA content and nucleation patterns in rat cardiac myocytes from different models of cardiac hypertrophy. J Mol Cell Cardiol 1992;24:497-505.
16. Hill MF, Signal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-40.
17. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002;415:240-3.
18. Kajstura J, Leri A, Finato N, di Loreto N, Di Loreto C, Beltrami CA et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95:8801-5.
19. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
20. Asahara T, Murohara T, Sullivan A, Silver M, Van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
21. Folkman J. Therapeutic angiogenesis in ischemic limbs. Circulation 1998;97:108-10.
22. Kalka C, Masuda H, Takahashi T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7.
23. Takahashi, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-8.
24. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-36.
25. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6.
26. Jaffredo T, Gautier R, Eichmann A, Dieterlen-Lievre F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 1998;125:4575-83.
27. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
28. Kamihata H, Matsubara H, Nishuie T, Fujiyama S, Tsutsumi Y, Ozono R et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation 2001;104:1046-52.
29. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
30. Pittenger MF, Mosca JD, McIntosh KR. Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 2000;251:3-11.
31. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994;83:939-48.
32. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14.
33. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
34. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
35. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73.
36. Thomson JA, Itskovits-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
37. Winston R. Embryonic stem cell research: the case for... Nat Med 2001;7:396-7.
38. Antoniou M. Embryonic: stem cell research: the case against... Nat Med 2001;7:397-9.
39. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-24.
40. Thompson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA et al. Isolation of a primate embryonic stem cell line. Proc Nat Acad Sci USA 1995;92:7844-8.
41. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004;350:1353-6. Epub 2004 Mar 03.
42. Hwang WS, Ryu YJ, Park JH, Park ES, Lee EG, Koo JM et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004;303:1669-74.
43. Thompson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
44. Zhang M, Methot D, Poppa V. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-21.
45. Lattanzi L, Salvatori G, Coletta M. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer: an alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 1998;101:2119-28.
46. El Oakley RM, Ooi OC, Bongso A, Yacoub MH. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 2001;71:1724-33.
47. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33.
48. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-23.
49. Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 1999;100:193-202.
50. Reinecke H, McDonald GH, Hauschka SD, Murry CE. Electro-mechanical coupling between skeletal and cardiac muscle: implications for infarct repair. J Cell Biol 2000;149:731-40.
51. Fuchs R, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-32.
52. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001;122:699-705.
53. Min JY, Yang Y, Converson KL, Liu L, Huang Q, Morgan JP et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002;92:288-96.
54. Torrente Y, Camirand G, Pisati F, Belicchi M, Rossi B, Colombo F et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 2003;162:511-20.
55. Lapidot T, Petit I. Current understanding of stem cells mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-81.
56. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
57. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9.
58. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-9.
59. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y et al. Bone marrow cells adopt phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-5.
60. Ying QL, Nichols J, Evans E, Smith AG. Changing potency by spontaneous fusion. Nature 2002;416:545-8.
61. Liu Y, Rao MS. Transdifferentiation: fact or artefact? J Cell Biochem 2003;88:29-40.
62. Hagège AA, Carrion C, Menasche, Vilquin JT, Duboc D, Marolleau JP et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-2.
63. Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, Pouzet B et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
64. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
65. Hamano K, Nishida M, Hirat K, Mikamo A, Li TS, Harada M et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001;65:845-7.
66. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002;106:3009-17.
67. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J et al. Infarct remodelling after intracoronary progenitor cell treatment in patients with acute myocardial infarction. Circulation 2003;108:2212-8.
68. Strauer B, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
69. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK et al. Effects of intracoronary infusion of peripheral blood stem cells mobilized with granulocyte -colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clnical trial. Lancet 2004;363:751-6.
70. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-9.
71. Fuchs S, Weisz G, Kornowski R et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility and safety study. Circulation. 2002;106 Suppl II:II655-6.
72. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. J Am Coll Cardiol 2003;41:879-88.
73. Dib N, Mc Carty P, McLellan WR et al. Long-term follow-up of safety and feasibility of autologous skeletal myoblast transplantation in patients undergoing coronary artery bypass graft surgery. American College of Cardiology, Annual Scientific Session, New Orleans, March 7-10, 2004.
74. Siminiak T. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure: The Poznan trial. American College of Cardiology, Annual Scientific Session, New Orleans, March 7-10, 2004.
75. Perin EC, Dohmann HFR, Borojevic R, Silva SA, Sousa AL, Mesquita CT et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302.
76. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T et al. Combined transplantation of autologous skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 2004;25:627-34.